Hot Life Science Investor Mandate 2: PE Firm Seeks Devices and Diagnostics

4 Jun

A US-based private equity firm founded in 2000 is actively investing from two funds. The firm currently has $150M in AUM. The group typically invests from $8M – 20M over the lifetime of an investment and anticipates investments in 2 – 3 platforms over the next year. Investments in the United States and Canada are of interest.

The firm primarily considers medical devices and diagnostics that overlap with or contribute to the healthcare IT and service landscapes, where they predominantly invest. The firm will consider all classes of medical devices. The group is agnostic in terms of indication.

The firm seeks a board seat and is extremely involved in management of portfolio companies. The group seeks a strong management team that has scaled a company in the past. The group prefers to leads investments but will consider co-investing. Growth-stage companies with products already on the market are the core focus of the firm. Though the firm prefers a positive cash flow, it will consider companies not yet making a profit, if the company has a controlled burn rate. The group will also consider add-on devices not yet on the market.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s

%d bloggers like this: